Abstract
The hydrodynamic tail vein injection is a technique that is used to deliver nucleic acids into live mice. Delivery through this method results in the in vivo transfection of foreign DNA primarily in the liver. Here, we describe the use of this technique to test for regulatory activity of liver promoters and enhancers, using a dual luciferase reporter system as the readable/measureable output and how this application can be used for pharmacogenomic studies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Zhang G, Budker V, Wolff JA (1999) High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum Gene Ther 10:1735–1737
Eggenhofer E et al (2009) High volume naked DNA tail-vein injection restores liver function in Fah-knock out mice. Hepatology 25:1002–1008
Herweijer H, Zhang G et al (2001) Time course of gene expression after plasmid DNA gene transfer to the liver. J Gene Med 3(3):280–291
Herweijer H, Wolff JA (2003) Progress and prospects: naked DNA gene transfer and therapy. Gene Ther 10:453–458
Herweijer H, Wolff JA (2007) Gene therapy progress and prospects: hydrodynamic gene delivery. Gene Ther 14:99–107
Lewis DL et al (2002) Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nat Genet 32:107–108
McCaffrey AP et al (2002) RNA interference in adult mice. Nature 418:38–39
Sen A et al (2003) Inhibition of hepatitis C virus protein expression by RNA interference. Virus Res 96:27–35
Song E et al (2003) RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med 9:347–351
Zender L et al (2003) Caspase 8 small interfering RNA prevents acute liver failure in mice. Proc Natl Acad Sci USA 100:7797–7802
Xu J et al (2005) Reduction of PTP1B by RNAi upregulates the activity of insulin controlled fatty acid synthase promoter. Biochem Biophys Res Commun 329:538–543
Keng VW et al (2011) Modeling hepatitis B virus X-induced hepatocellular carcinoma in mice with the sleeping beauty transposon system. Hepatology 53:781–790
Zhou T et al (2010) Intracellular gene transfer in rats by tail vein injection of plasmid DNA. AAPS J 12:692–698
Chalasani N et al (2010) Genome-wide association study identifies variants associated with histologic features of nonalcoholic fatty liver disease. Gastroenterology 139:1567–1576
Zhang H et al (2010) Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers. Nat Genet 42:755–758
Chen WM et al (2008) Variations in the G6PC2/ABCB11 genomic region are associated with fasting glucose levels. J Clin Invest 118:2620–2628
Schadt EE et al (2008) Mapping the genetic architecture of gene expression in human liver. PLoS Biol 6:1020–1032
MIRUS, TransIT®-EE Hydrodynamic Delivery Solution Protocol. http://www.mirusbio.com/assets/cms_files/protocols/ML043.pdf. Accessed July 2011
Choi JH et al (2009) Identification and characterization of novel polymorphisms in the basal promoter of the human transporter, MATE1. Pharmacogenet Genomics 19:770–780
Kim MJ et al (2011) Functional characterization of liver enhancers regulating drug-associated transporters. Clin Pharmacol Ther 89:571–578
Simonet WS et al (1993) A far-downstream hepatocyte-specific control region directs expression of the linked human apolipoprotein E and C-I genes in transgenic mice. J Biol Chem 268:8221–8229
Caliper Life Sciences, IVIS® Lumina II. http://www.caliperls.com/products/preclinical-imaging/ivis-luminaii.htm. Accessed July 2011
Promega Corporation, Dual-Luciferase® Reporter Assay Technical Manual. http://www.promega.com/resources/protocols/technical-manuals/0/dual-luciferase-reporter-assay-system-protocol/. Accessed July 2011
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Kim, M.J., Ahituv, N. (2013). The Hydrodynamic Tail Vein Assay as a Tool for the Study of Liver Promoters and Enhancers. In: Innocenti, F., van Schaik, R. (eds) Pharmacogenomics. Methods in Molecular Biology, vol 1015. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-435-7_18
Download citation
DOI: https://doi.org/10.1007/978-1-62703-435-7_18
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-434-0
Online ISBN: 978-1-62703-435-7
eBook Packages: Springer Protocols